Stelios Papadopoulos - May 11, 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
Stock symbol
EXEL
Transactions as of
May 11, 2021
Transactions value $
-$6,394
Form type
4
Date filed
5/13/2021, 08:32 PM
Next filing
May 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $252K +40K +3.36% $6.30 1.23M May 11, 2021 Direct F1
transaction EXEL Common Stock Sale -$255K -10.2K -0.83% $24.95 1.22M May 11, 2021 Direct F2
transaction EXEL Common Stock Options Exercise $125K +40K +3.28% $3.13* 1.26M May 11, 2021 Direct
transaction EXEL Common Stock Sale -$127K -5.08K -0.4% $25.00 1.25M May 11, 2021 Direct F3
transaction EXEL Common Stock Options Exercise $135K +40K +3.19% $3.38* 1.29M May 11, 2021 Direct
transaction EXEL Common Stock Sale -$137K -5.47K -0.42% $25.01 1.29M May 11, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -40K -100% $0.00* 0 May 11, 2021 Common Stock 40K $6.30 Direct F5
transaction EXEL Option (right to buy) Options Exercise $0 -40K -100% $0.00* 0 May 11, 2021 Common Stock 40K $3.13 Direct F6
transaction EXEL Option (right to buy) Options Exercise $0 -40K -100% $0.00* 0 May 11, 2021 Common Stock 40K $3.38 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 15,538 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.93 to $24.97. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.99 to $25.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016.
F6 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.
F7 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.